Previous Close | 0.0150 |
Open | 0.0150 |
Bid | 0.0100 x 0 |
Ask | 0.0150 x 0 |
Day's Range | 0.0100 - 0.0150 |
52 Week Range | 0.0050 - 0.0650 |
Volume | |
Avg. Volume | 707,845 |
Market Cap | 3.159M |
Beta (5Y Monthly) | 3.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Toronto, Ontario--(Newsfile Corp. - May 22, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announces that it proposes to undertake a non-brokered private placement of up to 100,000,000 units priced at $0.01 per unit for total proceeds of $1,000,000 (the "Offering"). Each unit will be comprised of one common share in the capital of ...
Toronto, Ontario--(Newsfile Corp. - March 21, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announced that its Board of Directors ("the Board") has initiated a review process to review, evaluate and explore a broad range of strategic initiatives and alternatives with the intent to maximize shareholder value. The strategic review process will involve
Company To Resume Trading on Toronto Stock Exchange Venture (TSXV) on February 7, 2024 Toronto, Ontario--(Newsfile Corp. - February 6, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, has received a letter from the Center of Medicare and Medicaid. The letter confirms that CMS is reopening the Company's application for its Venowave device for considerat